Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

August 31, 2011

Conditions
Skin UlcersMethicillin-resistant Staphylococcus Aureus Infection
Interventions
DRUG

Nitric Oxide

Gaseous nitric oxide (1%), delivered for 30 minutes per day for 3 consecutive days

Trial Locations (1)

CF14 4XN

Department of Wound Healing, Cardiff University, Cardiff

Sponsors
All Listed Sponsors
lead

Nitric BioTherapeutics, Inc

INDUSTRY

NCT00790608 - Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA) | Biotech Hunter | Biotech Hunter